Activities of Monica MACOVEI related to 2011/2220(DEC)
Reports (2)
SECOND REPORT on discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2010 PDF (181 KB) DOC (97 KB)
REPORT on discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2010 PDF (219 KB) DOC (147 KB)
Amendments (86)
Amendment 2 #
Proposal for a decision 1
Paragraph 1
Paragraph 1
1. ...Postpones its decision on granting the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year 2010;
Amendment 3 #
Proposal for a decision 1
Paragraph 1
Paragraph 1
1. ...Grants the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year 2010;
Amendment 4 #
Proposal for a decision 2
Paragraph 1
Paragraph 1
1. ...Approves the closure of the accounts of the European Medicines Agency for the financial year 2010;
Amendment 5 #
Motion for a resolution
Recital A
Recital A
Amendment 5 #
Proposal for a decision 2
Paragraph 1
Paragraph 1
1. ...Postpones the closure of the accounts of the European Medicines Agency for the financial year 2010;
Amendment 6 #
Motion for a resolution
Recital A a (new)
Recital A a (new)
A a. whereas on 10 May 2012, the European Parliament postponed its decision on the discharge and closure of the accounts of the Agency for the financial year 2010,
Amendment 6 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Calls on the Agency and on the IAS to immediately verify whether all the actions mentioned in the audit reports, including the one for 2010, were fully implemented and to inform the discharge authority accordingly;
Amendment 7 #
Motion for a resolution
Recital A b (new)
Recital A b (new)
A b. whereas the Agency addressed to a large extent the weaknesses highlighted in the report of 10 May 2012 and provided the discharge authority with substantial information by letters of 2 and 6 July 2012 and of 2, 7 and 24 August 2012,
Amendment 7 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Is concerned that the Management Board of the Agency never sent the Action Plan and insists on receiving it immediatelyNotes from the Agency that on 15 December 2011 the Management Board endorsed the proposal for the Agency to present at the June 2012 Management Board the detailed implementing measures related to: - establishment of the new structure and scope of the Advisory Committee on Procurement and Contract, - implementation of a multiannual procurement plan, - establishment of the responsibility of the above; insists that the Management Board of the Agency sends the Action Plan to the discharge authority at the latest by 30 June 2012;
Amendment 8 #
Motion for a resolution
Recital B
Recital B
Amendment 9 #
Motion for a resolution
Recital C
Recital C
Amendment 9 #
Motion for a resolution
Paragraph 8
Paragraph 8
8. Notes weaknesses in the Agency's system for validating creditor claims in respect of IT contractors; calls therefortakes note onf the Agency to promptly address the situ's statement that the weaknesses noticed by the Court of Auditors were related to a human error and corrected, that it has strengthened its ex-ante operational and finform the discharge authority on the actiancial control of invoices and that no further weaknesses have been detected; invites the Court of Auditors to verify and inform Parliament ons takenhis matter;
Amendment 10 #
Motion for a resolution
Recital D
Recital D
Amendment 11 #
Motion for a resolution
Recital E
Recital E
Amendment 12 #
Motion for a resolution
Recital F
Recital F
Amendment 13 #
Motion for a resolution
Paragraph 1
Paragraph 1
Amendment 13 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Establishes from the Agency's Report on budgetary and financial management that, in 2010, appropriations totalling EUR 9 074 296.,49 were cancelled compared with EUR 7 693 276.,58 in 2009; notes the Agency's reply that the level of cancelled expenditure appropriations is a result of stringent monitoring of the actual revenue and adjustments to the expenditure; urges the Agency to take immediate action to decrease the level of cancelled appropriations and to adopt an Action Plan with concrete measures - including aimed at a stricter estimation of the fee income and the period to be received - and deadlines to address this persistent problem by 30 June 2012;
Amendment 15 #
Motion for a resolution
Paragraph 2
Paragraph 2
Amendment 16 #
Motion for a resolution
Paragraph 3 – introductory part
Paragraph 3 – introductory part
3. Notes from the Agency that on 15 Decemberthat on 7 June 20112 the Management Board endorsed a proposal for the Agency to pthe new structure and scope of the Advisory Committee on Procuresment at the June 2012 meeting of the Management Board the detailed implementing measures related to the:nd Contract; welcomes that the Agency put in place a multiannual procurement plan for 2012- 2014 as requested by the discharge authority in its report on the discharge for the financial year 2009;
Amendment 17 #
Motion for a resolution
Paragraph 3 – indent 1
Paragraph 3 – indent 1
Amendment 18 #
Motion for a resolution
Paragraph 3 – indent 2
Paragraph 3 – indent 2
Amendment 18 #
Motion for a resolution
Paragraph 17
Paragraph 17
17. Notes that by refusing a new payment system, the Management Board accepts and takes direct responsibility for very important risks, such as the non- compliance with legislative requirements, the potential financial impact of the current remuneration system, and reputation; is therefore not ready to accept this questionable attitude from the Agency's GoverningManagement Board and calls upon them to take immediate aadopt an Action Plan on this and to inform the discharge authority by 30 June 2012;
Amendment 19 #
Motion for a resolution
Paragraph 3 – indent 3
Paragraph 3 – indent 3
Amendment 19 #
Motion for a resolution
Paragraph 21
Paragraph 21
21. Urges alsonderlines that the Agency needs to finalise the signing of an MoU on independence of scientific evaluation, amend internal procedures correspondingly, and update the experts' database; calls on the Agency andtakes note of the Agency's reply that MoUs on independence of scientific evaluation have been signed as of October 2011 and that the experts database was updated to allow direct upload of the e- DoI into the database; calls on the Agency to inform the discharge authority on the status of implementation of these measures by 30 June 2012; also invites the IAS to inform the discharge authority when these very important recommendations are effectively implemented by the Agency;
Amendment 20 #
Motion for a resolution
Paragraph 3 – subparagraph 1
Paragraph 3 – subparagraph 1
Amendment 21 #
Motion for a resolution
Subheading 2
Subheading 2
Amendment 22 #
Motion for a resolution
Paragraph 4
Paragraph 4
Amendment 22 #
Motion for a resolution
Paragraph 23
Paragraph 23
23. CTakes note from the Agency of the adoption on 1 February 2012 of the "Decision on rules relating to Articles 11a and 13 of the Staff Regulations concerning the handling of declared interests of employees of the European Medicines Agency" by the Management Board and of the "Decision on rules concerning the handling of declared interests of national experts on secondment, visiting experts, trainees and interims of the European Medicines Agency" by the Executive Director; calls on the Agency to provide the discharge authority with the guidelinconcrete measures aund assessment criteria onertaken to implement these Decisions by 30 June 2012 in order to enable Parliament to assess the concrete handling of potential conflicts of interest of staff memberfor all categories listed in the two Decisions;
Amendment 23 #
Motion for a resolution
Paragraph 5
Paragraph 5
Amendment 24 #
Motion for a resolution
Paragraph 6
Paragraph 6
Amendment 25 #
Motion for a resolution
Paragraph 7
Paragraph 7
Amendment 26 #
Motion for a resolution
Paragraph 8
Paragraph 8
Amendment 26 #
Motion for a resolution
Paragraph 25 a (new)
Paragraph 25 a (new)
25 a. Recalls that, following the employment of the Agency's former Executive Director by a consultancy that advises, among others, pharmaceutical companies almost immediately after he left the Agency, the discharge authority raised concerns on the actual independence of the Agency and the way its Management Board implemented Article 16 of the Staff Regulations; is furthermore concerned by the allegations that the Agency's former Executive Director created his own consultancy firm while still in office; calls on the Agency to provide the discharge authority with further information on this matter by 30 June 2012;
Amendment 27 #
Motion for a resolution
Paragraph 9
Paragraph 9
Amendment 28 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Is concernedReminds that the Court of Auditors has once more reported a high carryover of EUR 17 600 000 in Title II (Administrative expenditure); stresses that this situation indicates delays in the implementation of activities financed from Title II of the Agency's budget and that the Agency is not complying with the budgetary principle of annualitylevel of carryovers for the financial year 2010 as well as a lack of compliance with the budgetary principle of annuality; welcomes the fact that the Agency has strengthened its procedures of fee revenue forecasting by creating a team which analyses, in close cooperation with the pharmaceutical industry, the status of pharmaceutical product research before submission to the Agency; notes the Agency's firm commitment to work with Directorate General Budget in order to achieve a stable framework with the current revision of the Framework Financial Regulations;
Amendment 29 #
Motion for a resolution
Paragraph 11
Paragraph 11
Amendment 29 #
Motion for a resolution
Paragraph 25 b (new)
Paragraph 25 b (new)
25 b. Welcomes the Agency's initiative to publish the declarations of interests of its staff members occupying management positions and of the experts involved in the evaluation of medicinal products on its website; notes with interest that the list of experts also indicates their risk level in terms of conflict of interest; believes that at least the previous working places – professional background – should also be publish along with the declarations of interest to allow verification of the declarations of interest and identify possible conflicts; invites therefore the Agency to provide the Parliament information on the status of implementation of these measures by 30 June 2012;
Amendment 30 #
Motion for a resolution
Paragraph 12
Paragraph 12
Amendment 31 #
Motion for a resolution
Paragraph 13
Paragraph 13
Amendment 31 #
Motion for a resolution
Paragraph 25 c (new)
Paragraph 25 c (new)
25 c. Is nevertheless concerned by the Agency's approach vis-à-vis the scrutiny of declarations of interest which is primarily based on trust rather than on verification; is notably concerned by the fact that the comparison of the experts' declaration of interest published by the relevant national agency and by the Agency reveals significant differences in some cases; calls therefore on the Agency to establish a genuine mechanism enabling for a proper scrutiny of the declarations of interest received by the Agency and to inform the discharge authority on this matter by 30 June 2012;
Amendment 33 #
Motion for a resolution
Paragraph 25 d (new)
Paragraph 25 d (new)
25 d. Notes that the Agency has been audited by the Court of Auditors in the framework of the Special Report on conflicts of interest management in the Union agencies; acknowledges from the Court of Auditors that the aforementioned Special Report will be published by the end of June 2012; is of the opinion that, given the extent of criticisms questioning conflict of interest issues in the Agency, the decision on the discharge should be postponed until the publication of the Special Report to take into account the findings of the Court of Auditors on this matter;
Amendment 34 #
Motion for a resolution
Subheading 4
Subheading 4
Amendment 35 #
Motion for a resolution
Paragraph 14
Paragraph 14
Amendment 36 #
Motion for a resolution
Paragraph 15
Paragraph 15
Amendment 38 #
Motion for a resolution
Paragraph 16
Paragraph 16
Amendment 39 #
Motion for a resolution
Paragraph 17
Paragraph 17
17. SGives full supports to all efforts at the executive and administrative levels of the Agency to reform the payment system for services provided by Member States' authorities which should clearly be based on the real costs; urges the Management Board to move forward on this issuewelcomes therefore the Agency's initiative to prepare a new proposal to be submitted to the Management Board; urges and expects the Management Board to discuss and decide on this payment system without delay;
Amendment 40 #
Motion for a resolution
Paragraph 18
Paragraph 18
Amendment 41 #
Motion for a resolution
Subheading 6
Subheading 6
Amendment 42 #
Motion for a resolution
Paragraph 19
Paragraph 19
Amendment 43 #
Motion for a resolution
Paragraph 20
Paragraph 20
Amendment 44 #
Motion for a resolution
Subheading 7
Subheading 7
Transparency and Management of conflict of interest
Amendment 45 #
Motion for a resolution
Paragraph 21
Paragraph 21
Amendment 46 #
Motion for a resolution
Paragraph 21 a (new)
Paragraph 21 a (new)
21 a. Takes note that the Agency is organising in November a workshop gathering a broad range of interested parties in the view of developing the modalities of providing public access to clinical trial data and that the selection and training of the Agency's scientific staff aimed at strengthening the analysis of raw data is well advanced;
Amendment 47 #
Motion for a resolution
Paragraph 22
Paragraph 22
Amendment 49 #
Motion for a resolution
Paragraph 23
Paragraph 23
Amendment 50 #
Motion for a resolution
Paragraph 24
Paragraph 24
Amendment 52 #
Motion for a resolution
Paragraph 25
Paragraph 25
25. Takes note fromthat the Agency of the adoption on 1 February 2012 of the ‘Decision on rules relating to Articles 11a and 13 of the Staff Regulations concerning the handlhas improved the scope and methodology of the systematic ex-ante and ex-post controls related to the screening of dDeclared interests of employees of the European Medicines Agency’ by the Management Board and of the ‘Decision on rules concerning the handling of declared interests of national experts on secondment, visiting experts, trainees and interims of the European Medicines Agency’ by the Executive Director; calls onation of Interest, also welcomes the Agency's decision to perform a yearly evaluation of its revised policy on Declaration of Interest; invites therefore the Agency to informkeep the discharge authority of the concrete measures undertaken to implement these decisions by 30 June 2012 in order to enable Parliament to assess the procedures in place for hinformed on the implementation of its revised policy andl ing potential conflicts of interest for all categories listed in the two decisions, plus the members of the Management Boardarticular of its systematic ex-ante and ex-post controls on a 6-month basis;
Amendment 53 #
Motion for a resolution
Paragraph 25 a (new)
Paragraph 25 a (new)
25 a. Notes with satisfaction that the Agency has started publishing the minutes of some Scientific Committees' meetings, starting with the Paediatric Committee (PDCO) in July 2012; takes note that the publication process of the minutes for all Scientific Committee meetings will be completed only by the end of 2013;
Amendment 55 #
Motion for a resolution
Paragraph 26
Paragraph 26
26. Notes withat the concern that ins raised with regard to the financial circuits there are alsoand the potential conflicts of interests in processing payments due to insufficient segregation of duties; urges the Agency therefore to duly take into account this very significant risk and take immediate action to address this deficiency were addressed by the Agency with the introduction of SAP accounting software as its central financial system;
Amendment 56 #
Motion for a resolution
Paragraph 27
Paragraph 27
Amendment 58 #
Motion for a resolution
Paragraph 27 a (new)
Paragraph 27 a (new)
27 a. Underlines that in June 2012 a 'revolving door' case occurred in the Agency, the former Head of Legal Service joined as senior counsel a US-based law firm having a number of pharmaceutical industry companies as clients; takes note that the Executive Director of the Agency launched a review of the work performed by the former Head of Legal Service; invites the Agency to inform the discharge authority on the outcomes of this review by the end of 2012;
Amendment 59 #
Motion for a resolution
Paragraph 28
Paragraph 28
Amendment 61 #
Motion for a resolution
Paragraph 28 a (new)
Paragraph 28 a (new)
28 a. Takes note that the Agency proceeded to a screening process of the declarations of interest of its experts and committee members who have been actively involved in the Agency's activities between 1 January and 31 May 2012 against their curriculum vitae; notes that around 54% of the experts and committee members provided the Agency with updated curriculum vitae; calls on the Agency to inform the discharge authority on the timeframe and outcomes of the screening process for the remaining 46% by the start of the next discharge procedure;
Amendment 62 #
Motion for a resolution
Paragraph 29
Paragraph 29
Amendment 63 #
Motion for a resolution
Paragraph 30
Paragraph 30
Amendment 64 #
Motion for a resolution
Paragraph 31
Paragraph 31
Amendment 66 #
Motion for a resolution
Paragraph 32
Paragraph 32
32. Welcomes the Agency's initiative to publish on its website the declarations of interests of its staff occupying management positions and of the experts involved in the evaluation of medicinal products on its website; notes with interest that the list of experts also indicates their risk level in terms of conflict of interest; believes that at least the previous working places – professional background – should also be published along with the declarations of interest to allow verification of the declarations of interest and identify possible conflicts; therefore invites the Agency to provide Parliament with information on the status of implementation of these measures by 30 June 2012welcomes the Agency's commitment to publish next to the declarations of interest the professional and educational profiles of the scientific experts belonging to its Expert Database from first quarter 2013 and will follow closely the publication process during the future discharge procedures;
Amendment 67 #
Motion for a resolution
Paragraph 33
Paragraph 33
Amendment 68 #
Motion for a resolution
Paragraph 34
Paragraph 34
Amendment 71 #
Motion for a resolution
Paragraph 34 a (new)
Paragraph 34 a (new)
34 a. Acknowledges the Agency's efforts to address the discharge authority's concerns with regards to the prevention and management of conflict of interest; notes in particular the reports of 29 June 2012 and 7 August 2012 received by the discharge authority on the review of the conflict of interest management cases identified by the IAS and on the review of potential conflicts of interest of experts involved in assessing the medicinal product Pandemrix;
Amendment 72 #
Motion for a resolution
Paragraph 34 b (new)
Paragraph 34 b (new)
34 b. Calls on the Agency to introduce in each of its annual activity report a special section describing the actions taken to prevent and manage conflict of interest, which shall include inter alia: - the number of alleged conflict-of- interest cases verified, - the number of revolving door cases, - the measures taken in each category of cases, - the number of breach of trust procedures launched and their outcomes - the sanctions applied;
Amendment 73 #
Motion for a resolution
Paragraph 35
Paragraph 35
Amendment 76 #
Motion for a resolution
Paragraph 36
Paragraph 36
Amendment 77 #
Motion for a resolution
Paragraph 37
Paragraph 37
Amendment 78 #
Motion for a resolution
Paragraph 38
Paragraph 38
Amendment 79 #
Motion for a resolution
Paragraph 39
Paragraph 39
Amendment 81 #
Motion for a resolution
Subheading 8
Subheading 8
Amendment 82 #
Motion for a resolution
Paragraph 40
Paragraph 40
Amendment 83 #
Motion for a resolution
Paragraph 41
Paragraph 41
Amendment 84 #
Motion for a resolution
Subheading 9
Subheading 9
Amendment 85 #
Motion for a resolution
Paragraph 42
Paragraph 42
Amendment 87 #
Motion for a resolution
Paragraph 43
Paragraph 43
Amendment 90 #
Motion for a resolution
Paragraph 44
Paragraph 44
Amendment 92 #
Motion for a resolution
Paragraph 45
Paragraph 45
Amendment 93 #
Motion for a resolution
Paragraph 46
Paragraph 46
Amendment 94 #
Motion for a resolution
Paragraph 47
Paragraph 47